Showing results (91-100 of 427) with videos related to

Sort By:
Pageof 43
Journal of Clinical Medicine|August 27, 2021
Robot-Assisted Intracorporeal Orthotopic Ileal Neobladder: Description of the "Shell" TechniqueRoberto Bianchi, Francesco Alessandro Mistretta, Gennaro Musi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 14, 2008
Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapyBarbara A Jereczek-Fossa, Dario Zerini, Andrea Vavassori, et al.
Clinical Genitourinary Cancer|March 10, 2012
Neuroendocrine differentiation in castration-resistant prostate cancer: a systematic diagnostic attemptDeliu-Victor Matei, Giuseppe Renne, Marcelo Pimentel, et al.
Clinical Genitourinary Cancer|February 14, 2017
High-Risk Prostate Cancer and Radiotherapy: The Past and the Future. A Benchmark for a New Mixed Beam Radiotherapy ApproachGiulia Marvaso, Barbara A Jereczek-Fossa, Giulia Riva, et al.
Clinical Genitourinary Cancer|February 24, 2022
Comparison Between Micro-Ultrasound and Multiparametric MRI Regarding the Correct Identification of Prostate Cancer LesionsVito Lorusso, Boukary Kabre, Geraldine Pignot, et al.
Asian Journal of Urology|August 4, 2023
Neuraxial anesthesia versus general anesthesia in patients undergoing three-dimensional laparoscopic radical prostatectomy: Preliminary results of a prospective comparative studyStefano Alba, Deborah Fimognari, Fabio Crocerossa, et al.
Cancer Causes & Control : CCC|January 30, 2020
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalitiesStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Clinical Genitourinary Cancer|March 9, 2020
Survival of Contemporary Patients With Non-metastatic Small-cell Carcinoma of Urinary Bladder, According to Alternative Treatment ModalitiesStefano Luzzago, Carlotta Palumbo, Giuseppe Rosiello, et al.
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Medical Physics|August 22, 2024
Addressing intra- and inter-institution variability of a radiomic framework based on Apparent Diffusion Coefficient in prostate cancerLetizia Morelli, Chiara Paganelli, Giulia Marvaso, et al.
Pageof 43